Canadian CANNAINVESTOR Magazine May 2017 - Page 133

According to the recent Globe and Mail article “Medicinal marijuana users skeptical of product safety after recalls for banned pesticides”, after a string of recent recalls for some LP’s because of the presence of myclobutanil and/or bifenazate – a banned pesticide that produces hydrogen cyanide when heated – a number of patients told The Globe and Mail they don’t see how Health Canada can assure them the product can be trusted. Health Canada has since attached new conditions to the licenses of Mettrum and OrganiGram, requiring their product to be tested for banned pesticides. It should be noted that Health Canada has recently announced that it will be conducting random tests for the rest of the industry as well, to ensure that everyone is complying with regulations. Given these recent pesticide recalls, this reason alone may sway users to at least try and do it themselves.

Moreover, companies such as Tweed (100% owned by Canopy Growth Corporation) for example, felt that it was important to serve home growing, and have taken every step possibly to support your home grow. In a recent discussion with Jordan Sinclair, Director of Communications and Media at Tweed Inc., he reiterated that the company “has been very vocal and very supportive of home growing for a very long time, being in the medical marijuana space. Tweed has ten strains available currently. It was important that we source really high quality feminized seeds and provide general guidance on our website on how to germinate seeds and get you on the right track. We offer a trusted source for getting started.”

Other companies such as THC BioMed International Ltd. (CSE:THC) not only provides scientific and biotechnological support services to a target demographic that includes current and potential licensed producers under the ACMPR, but have starting materials (clones) available through their online shop “Seeds R Us”, as well as a THC Cultivator unit that is in the works.

133